your partner in preclinical research

Let urosphereestablish the preclinical proof of concept for your drug candidates.

Read more

A new era is beginning for UROSPHERE.

We extend our activities to GASTROENTEROLOGY and ONCOLOGY.

UROsphere becomes urosphere+

logotype-vector_corporate-H

Your partner in preclinical research

Urosphere is a leading Contract Research Organization specializing in preclinical urogenital, gastro-intestinal and oncological pharmacology assays. We provide the pharmaceutical and biopharmaceutical industries with a unique experimental research platform combining both in vivo models and in vitro assays on human and animal tissues.

Learn more about us

News & eventS

Events // News & Events // Jun 25 2019

Urosphere participe à la 7e édition des AFSSI Connexions les 2/3 juillet 2019 à Lyon

  Urosphere sera présente sur l’espace village AFSSI les 2 et 3 juillet 2019 à Lyon. N'hésitez pas à venir nous voir sur le stand.  

Read more

Events // News & Events // May 17 2019

Urosphere/ Urolead and Institut Curie will present their last results at the AACR...

    Fruit of a long term collaboration, Urosphere and its affiliate Urolead (Toulouse) and Institut Curie (Paris) will present a fully characterized biobank of PDXs from...

Read more

Events // News // News & Events // Mar 07 2019

Urosphere will be present at the European Association of Urology congress 2019.


    Urosphere will present a poster at the EAU congress (from 15 to 19 March 2019). Poster 500:Patard PM et al.,Characterization of bladder organoid cultures...

Read more

News // News & Events // May 23 2018

DMS : finalisation d'une étude préclinique sur le traitement des dysfonctions érectiles.

Voir le communiqué de presse

Read more

Events // News // News & Events // Oct 31 2017

AACR-NIC-EORTC conference in Philadelphia, from Oct 26th to Oct 31st.

Urosphere / Urolead will be represented by Repositive’s CEO Fiona Nielsen at the AACR-NIC-EORTC conference in Philadelphia, from Oct 26th to Oct 31st. Come and meet her at booth 817.

Read more
All news

Publications

Oncology // Publications // Oct 31 2017

[Poster] Effects of litoxetine on urethral pressure and detrusor overactivity in anesthetized...

Effects of litoxetine on urethral pressure and detrusor overactivity in anesthetized female rats. Murielle Méen, Marc Guérard, Stefano Palea, Xavier Gamé, Philippe Lluel 32nd Annual...

Read more

Publications // Urology // Oct 31 2017

[Poster] Effects of litoxetine on acetic acid-induced detrusor overactivity and striated...

Effects of litoxetine on acetic acid-induced detrusor overactivity and striated anal sphincter functions in rabbits: comparison with duloxetine. Fernando Pérez-Martinez, Philippe...

Read more

Publications // Oct 31 2017

Effect of OBE022, an Oral and Selective Non-Prostanoid PGF2α Receptor Antagonist...

Effect of OBE022, an Oral and Selective Non-Prostanoid PGF2α Receptor Antagonist in Combination with Nifedipine for Preterm Labor: A Study on RU486-Induced Pregnant Mice. Oliver Pohl,...

Publications // Urology // Oct 31 2017

Treatment with WS® 1541 leads to a reduction of gene expression for proinflammatory...

Treatment with WS® 1541 leads to a reduction of gene expression for proinflammatory mediators and growth factors in the prostate of rats with sulipride-induced BPH. Kraft S, Nöldner...

Publications // Urology // Oct 31 2017

Cultures d’organoïdes de vessie humaine : un nouveau modèle d’étude.

Cultures d’organoïdes de vessie humaine : un nouveau modèle d’étude. Tostivint V, Vergnolle N, Ferrand A, Lluel P, Gamé X, Chabot S, Rouget C, Beauval JB Prog Urol. 2016 Nov;26(13):765-766.

All publications